Article
The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling.
Kidney international - 1 Jun 2018
Barrera-Chimal Jonatan, Estrela Gabriel R, Lechner Sebastian M, Giraud Sébastien, El Moghrabi Soumaya, Kaaki Shiem, Kolkhof Peter, Hauet Thierry, Jaisser Frédéric
Abstract excerpt
Acute kidney injury induced by ischemia/reperfusion is an independent risk factor for chronic kidney disease. Macrophage recruitment plays an essential role during the injury and repair phases after an ischemic episode in the kidney. Here we show that the novel non-steroidal mineralocorticoid receptor antagonist finerenone or selective myeloid mineralocorticoid receptor ablation protects against subsequent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
